Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01381354 · ClinicalTrials.gov registry record · Phase 1

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

A Phase 1 study, sponsored by University of Iowa.

Completed
Registry status
Phase 1
Development phase
38
Enrollment target

NCT01381354 is a Phase 1 study that has completed, run by University of Iowa. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01381354, a Phase 1 study, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
Phase 1
Development phase
38 participants
Enrollment target

Study Summary

The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of gait and fatigue disability in the setting of secondary and primary progressive multiple sclerosis with gait disability.

Interventions

  • OTHER Progressive exercise
  • DIETARY_SUPPLEMENT Omega 3 fatty acids
  • DEVICE Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV
  • OTHER Modified paleolithic diet
  • DIETARY_SUPPLEMENT Full Spectrum vitamin

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2010-10
Est. Completion 2016-05
Phase Phase 1

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT01381354

The ClinicalTrials.gov registry entry for NCT01381354 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Progressive exercise is the first listed.

NCT01381354 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01381354 about?

NCT01381354 is a clinical study titled "Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)". The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of ga...

What is the current status of trial NCT01381354?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2010-10. Estimated completion is 2016-05.

What interventions are being tested in trial NCT01381354?

The interventions under investigation include: Progressive exercise (OTHER), Omega 3 fatty acids (DIETARY_SUPPLEMENT), Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV (DEVICE), Modified paleolithic diet (OTHER), Full Spectrum vitamin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01381354?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.